The Function of Hypoxia-Inducible Factor (HIF) Is Independent of the Endoplasmic Reticulum Protein OS-9 by Brockmeier, Ulf et al.
The Function of Hypoxia-Inducible Factor (HIF) Is
Independent of the Endoplasmic Reticulum Protein OS-9
Ulf Brockmeier
1., Corinna Platzek
2., Kirsten Schneider
1, Pauline Patak
3, Andre ´ Bernardini
1, Joachim
Fandrey
1, Eric Metzen
1*
1Institute of Physiology, University of Duisburg-Essen, Essen, Germany, 2Institute of Physiology, University of Lu ¨beck, Lu ¨beck, Germany, 3Department of Neurology,
University of Duisburg-Essen, Essen, Germany
Abstract
The protein ‘‘amplified in osteosarcoma-9’’ (OS-9) has been shown previously to interact with the prolyl hydroxylases PHD2
and PHD3. These enzymes initiate oxygen-dependent degradation of the a-subunit of hypoxia-inducible factor (HIF), a
transcription factor that adapts cells to insufficient oxygen supply (hypoxia). A new model has been proposed where OS-9
triggers PHD dependent degradation of HIF-a. It was the aim of our study to define the molecular mode of action of OS-9 in
the regulation of PHD and HIF activity. Although initial co-immunoprecipitation experiments confirmed physical interaction
between OS-9 and PHD2, neither overexpression nor lentiviral inhibition of OS-9 expression affected HIF regulation.
Subcellular localization experiments revealed a distinct reticular staining pattern for OS-9 while PHD2 was mainly localized
in the cytoplasm. Further cell fractionation experiments and glycosylation tests indicated that OS-9 is a luminal ER protein. In
vivo protein interaction analysis by fluorescence resonance energy transfer (FRET) showed no significant physical interaction
of overexpressed PHD2-CFP and OS-9-YFP. We conclude that OS-9 plays no direct functional role in HIF degradation since
physical interaction of OS-9 with oxygen sensing HIF prolyl hydroxylases cannot occur in vivo due to their different
subcellular localization.
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Introduction
In yeast two hybrid screens ‘‘amplified in osteosarcoma-9’’ (OS-
9) was identified as a protein which represses the transcription
factor hypoxia-inducible factor (HIF) by activation of two enzymes
that initiate oxygen-dependent degradation of HIF-a subunits [1].
Subsequently, it was reported that OS-9 is involved in endoplas-
mic reticulum associated degradation (ERAD) of misfolded
proteins [2,3]. It is still unclear whether these reports reflect the
involvement of OS-9 in two unrelated pathways of cell
metabolism, or, alternatively, suggest that OS-9 connects ERAD
to hypoxic signaling. With the current study we intended to
elucidate the molecular function of OS-9 in the regulation of HIF.
Molecular oxygen is the terminal electron acceptor in oxidative
phosphorylation of eukaryotic cells. Coupling the breakdown of
nutrients to mitochondrial respiration allows generation of much
larger amounts of ATP than for example anaerobic glycolysis.
Insufficient supply with oxygen, i.e. hypoxia, leads to cellular
responses intended to improve oxygen delivery and to adapt
metabolism to this stressful situation. A key role in this response is
played by the transcription factor HIF that orchestrates the
responses of the cells by activating transcription of an array of
hypoxia-inducible genes [4]. HIF target genes include erythropoi-
etin, vascular endothelial growth factor, virtually all glycolytic
enzymes, membrane bound glucose transporters, and many others
[5]. HIF binds to regulatory DNA regions as a heterodimer
composed of an a-subunit which is quickly degraded when oxygen
is abundant and a b-subunit, a nuclear protein independent of
oxygen concentration. Three distinct a-subunits have been
identified so far: HIF-1a and HIF-2a share similar modes of
regulation and have an overlapping set of target genes while HIF-
3a can act as an inhibitor of hypoxia-inducible signaling. All HIF-
a subunits share the same mode of oxygen-dependent regulation
which virtually eliminates HIF signaling in normoxia and
strikingly induces expression of HIF target genes in hypoxia:
three prolyl hydroxylases (PHD 1–3) oxidatively modify HIF-a at
proline residues that are embedded in a Leu-Xaa-Xaa-Leu-Ala-
Pro motif where Xaa depicts a non-conserved amino acid. With
respect to human HIF-1a the proline residues Pro564 and Pro402
undergo hydroxylation. The next step in the degradation cascade
is binding of the von-Hippel-Lindau protein (pVHL) which binds
hydroxylated HIF-a selectively. Binding of pVHL is followed by
ubiquitination and rapid proteasomal degradation. Despite
constant production HIF-a isoforms have a half life of approxi-
mately 5 minutes in normoxia. In addition, the enzyme ‘‘factor
inhibiting HIF-1’’ (FIH-1) hydroxylates an asparagine residue in
the C-terminal transactivation domain. This reaction abrogates
recruitment of transcriptional co-activators such as p300/CBP and
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oxygen-dependent manner.
Enzymatic activity of the HIF hydroxylases is apparently tightly
controlled. Molecular oxygen has two opposing effects: initially
low oxygen concentrations limit enzyme turnover because the
PHDs have a low affinity to oxygen as compared to collagen
hydroxylases for example. Suppression of PHD activity results in
HIF activation leading to enhanced transcription of the PHD2 and
the PHD3 genes which have been demonstrated to be HIF targets.
In turn, an increase in the expression of PHD2 and PHD3 limits
HIF activity despite continuous hypoxia. In addition, PHD activity
is also controlled by metabolites of the tricaboxylic acid (TCA)
cycle. Succinate, lactate, pyruvate, fumarate, and oxaloacetate
have been demonstrated to inhibit HIF hydroxylases although
primary data have not been entirely consistent. It has been
reported, however, that elevated levels of succinate and fumarate
in succinate dehydrogenase or fumarate hydratase deficient
tumors inhibit HIF hydroxylases and, as a consequence, activate
HIF [6,7]. Furthermore, our own data showed that nitric oxide
(NO) can inhibit the HIF prolyl hydroxylases by direct inhibition
of the enzyme reaction [8].
Currently, PHD2 is regarded as the dominant cellular oxygen
sensor protein. This is supported by siRNA experiments in which
inhibition of PHD2 led to a normoxic activation of HIF while
abrogation of PHD1 or PHD3 expression did not have this effect
[9]. Genetic ablation of PHD2 leads to prenatal death because of
placental malformation while PHD1 and PHD3 deficient mice
develop normally [10]. In adult life, PHD2 plays a prominent role
in erythropoiesis [11], angiogenesis [12], matrix synthesis of
human chondrocytes [13] and probably other processes which
require HIF activation in response to hypoxia. In a pathophys-
iological situation, loss of PHD2 promotes tumor growth because
angiogenesis and recruitment of bone marrow-derived cells is
enhanced [14]. Interestingly, heterozygous deficiency for PHD2 in
the stroma of the tumor leads to maturation of the endothelium
and inhibits metastasis [15]. Clearly, understanding how PHD2
activity is regulated is of high importance in physiology and
pathology.
In an early report PHD2 was purified from rabbit reticulocyte
lysate. Interestingly, while the calculated molecular mass of PHD2
is approximately 46 kDa, the purified complex had an apparent
molecular weight of 320–440 kDa under non-reducing conditions
[16]. This finding suggests either that PHD2 is present in the
complex as a multimer or that it is bound to other proteins which
affect PHD2 function either as scaffold proteins or even truly
regulatory subunits of the PHD complex. It was not possible so far
to crystallize full length enzyme. PHD2 bearing an N-terminal
deletion (PHD2181–426) forms a homotrimer [17] which is
insufficient to explain the size of the complex. Some reports have
provided evidence that the PHDs indeed have other substrates
than HIF-a [18–20], these interactions are, however, expected to
be transient in nature. Only a few proteins have been identified to
interact with PHD2 without being substrates. These include the
‘‘inhibitor of growth, family member 4’’ (ING4, [21]), and OS-9
[1]. The repression of HIF activity by ING4 appeared to be
unrelated to enzymatic PHD2 activity, but was instead dependent
on the recruitment of transcriptional repressors. In contrast, the
repression of HIF by OS-9 was interpreted as an activation of
hydroxylase activity, and therefore seemed to be of particular
interest.
The OS-9 gene was mapped to chromosome 12q13-15.
Homologs of OS-9 were identified in yeast and the nematode
worm C. elegans. The human OS-9 gene encodes a full length
protein of 667 amino acid residues [22]. Shorter splice variants
were also identified [23]. The function of the protein remained
enigmatic until human OS-9 and its yeast homolog Yos9 were
implicated in ER to Golgi transport. Notably, the subcellular
localization of the protein was controversial as one group of
investigators provided evidence that it is a luminal ER protein
while another found OS-9 to be attached to the ER membrane but
exposed to the cytoplasmic side of the membrane [24,25]. Very
recently, it was reported that OS-9 is part of the Hrd1-SEL1L
multiprotein complex which is involved in retrotranslocation of
misfolded proteins from the ER to the cytosol for ubiquitin
dependent degradation [2]. ER associated degradation (ERAD) is
of major cell physiological importance since it represents an
important quality control mechanism for newly synthesized
proteins. Within this process, the function of OS-9 is to bind
ERAD substrates together with the ER chaperone GRP94 and to
transfer the misfolded proteins to the ER membrane bound
ubiquitin ligase Hrd1 [3]. The precise way in which OS-9
discriminates misfolded proteins is still unclear.
The divergent reports on OS-9 function suggested that this
protein may connect HIF regulation to ER metabolism.
Remarkably, effects of ER stress or intracellular calcium depletion
on HIF regulation have been the subject of several publications
[26–28]. It was the aim of our study to illuminate the molecular
effects which link ER dependent metabolic steps to the regulation
of the transcription factor complex HIF.
Materials and Methods
Antibodies and reagents
The monoclonal antibody against human HIF-1a (610959) was
purchased from BD Biosciences (Heidelberg, Germany). Poly-
clonal antibodies against OS-9 (NB100-520) and PHD2 (NB100-
137) were from Novus Biologicals (Littleton, USA). The polyclonal
antibodies against actin (A2103), BiP (G6818), a-tubulin
(SAB3500023) and GAPDH (G9545) were from Sigma (Munich,
Germany). Polyclonal anti-lamin A (ab26300) was from Abcam
(Cambridge, UK). The monoclonal, biotinylated antibody against
V5-tag (MCA1360B) was purchased from AbD Serotec (Du ¨ssel-
dorf, Germany). The goat polyclonal, HRP-conjugated antibodies
raised against rabbit (PO448) and mouse (PO447) IgG were
purchased from DAKO (Hamburg, Germany). Thapsigargin,
tunicamycin, puromycin, polybrene, ampicillin, kanamycin, cy-
cloheximide and concanavalin A (C7275) were purchased from
Sigma. Endo H and PNGase F were obtained from NEB
(Frankfurt, Germany). Turbofect, T4 DNA ligase and all
restriction enzymes were from Fermentas (St. Leon-Rot, Ger-
many). Dimethyloxalylglycine (DMOG) was purchased from
Alexis Biochemicals (Lo ¨rrach, Germany). Epoetin beta was
purchased from Roche (Mannheim, Germany).
Bacterial strains, plasmids and DNA manipulation
E. coli XL1-blue (Stratagene, Heidelberg) served as the host for
general cloning and plasmid preparation, E. coli Stbl3 (Invitrogen,
Darmstadt, Germany) was used for production of the lentiviral
vectors pLKO.1 (8453, Addgene) and pLKO.1-shRNA-OS9
(TRCN0000156713, Sigma), the latter containing the 21 nucleotide
sequence GCATCGTCTTAAACGCTACCA, corresponding to
nucleotides 533–553 of OS-9 mRNA (GenBank accession number
AB002806). Both E.coli strains were grown in LB-medium
supplemented with either 100 mg/ml ampicillin or 40 mg/ml
kanamycin for plasmid selection. Plasmid preparation for transient
transfection into mammalian cells was performed with the High-
Speed Plasmid MidiKit from Qiagen (Hilden, Germany). Plasmids
encoding V5- and hexahistidine-tagged versions of PHD2 which
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from plasmids published earlier [29]. The cDNA containing the full
length OS-9 coding sequence was generously provided by Dr.
Gregg Semenza (pcDNA3.1(D)/V5-His-OS-9, encoding for a C-
terminal V5-His-tag and denominated pOS-9-V5 in our experi-
ments). To generate the plasmid pEYFP-N1-OS-9 encoding OS-9
fused to the N-terminus of EYFP, a PCR was performed with
forward primer 59-ATATAAGCTTGCCACCATGGCGGCG-
GAAACGCTGCTG-39 and reverse primer 59-ATATATAC-
CGGTGGGAAGTCAAATTCGTCCAGGTC-39 thereby intro-
ducing restriction sites HindIII and AgeI (underlined) for subcloning
into pEYFP-N1 (Clontech, Saint-Germain-en-Laye, France). For
cloning of untagged full length OS-9.1 cDNA into pcDNA3
(Invitrogen), a PCR was performed with the same forward primer
and the reverse primer 59-ATATATGCGGCCGCTCAGAAGT-
CAAATTCGTCCAG-39 which contains a NotI site. To create
expression plasmids for ECFP- and EYFP- tagged PHD2, the
PHD2 coding sequence was transferred from pEGFP-N1-PHD2
[29] to pECFP-N1 and pEYFP-N1 (Clontech) by restriction
digestion and ligation into the recipient vector. To generate
expression plasmids for ECFP- and EYFP-fused GRP94, the cDNA
of GRP94 was amplified by PCR with forward primer 59-
ATATATCTCGAGGCCACCATGAGGGCCCTGTGGGTGC-
TG-39 and reverse primer 59-ATATATGGATCCAGCAATT-
CATCTTTTTCAGCTGT-39 using pCMV-SPORT6-cDNA-
Grp94 (Imagenes, Berlin, Germany) as the template. The
corresponding PCR fragment was cloned into the plasmids
pECFP-N1 and pEYFP-N1 via the restriction sites BamHI and
XhoI (underlined). The integrity of each construct was confirmed by
DNA sequencing. For transient expression of the ECFP-FKBP38
fusion protein, pECFP-C1-FKBP38 [30] was used.
Cell culture, transfection and lentiviral transduction
U2OS, HEK 293, HEK 293T, HeLa, MCF-7, UT-7, and
Hep3B cells were obtained from the American Type Culture
Collection. Human foreskin fibroblasts and human umbilical vein
endothelial cells (HUVEC) were provided by Promocell, Heidel-
berg, Germany. U2OS, HEK 293, HEK 293T, HeLa, MCF-7,
Hep3B, and the fibroblasts were cultured in high glucose DMEM
(Invitrogen) supplemented with 10% FBS, 2 mM glutamine and
antibiotics. The non-adherent UT-7 cells were cultured in
DMEM/F12 (Invitrogen) supplemented with 1 U erythropoie-
tin/mL. HUVEC were maintained in Endothelial Cell Growth
Medium (Promocell). To generate oxygen concentrations close to
anoxia, cells were incubated in GasPak (BBL) anoxic jars with the
BD GasPak EZ anoxic container system. Transient transfections
were conducted using Turbofect (Fermentas) in a ratio 2:1 (ml
reagent/mg DNA) as recommended by the manufacturer. For
production of recombinant lentivirus, 1610
6 HEK 293T cells
were co-transfected for 4 h with 6 mg of the target vector pLKO.1-
shRNA-OS-9, 4 mg of psPAX2 (12260, Addgene) and 2 mg
pMD2G-VSVG (12259, Addgene). After exchange of the
medium, the cells were incubated for 60 hours. The medium
containing recombinant lentivirus was harvested, filtered through
a 0.45 mm filter unit (Schwalbach, Germany) and stored at
280uC. Functional virus titer was calculated by infecting HEK
293T cells with limiting virus dilutions of the GFP-carrying vector
pLS-CG (12161, Addgene) and subsequent quantification of GFP
positive cells by fluorescence microscopy. On average, the viral
titer was 1610
6 transduction units/ml. For transduction, 2610
5
U2OS cells were incubated for 16 hours with lentiviral superna-
tant (2610
6 transduction units) containing polybrene (8 mg/ml).
Lentivirus infected U2OS cells were maintained in DMEM
containing 1 mg/ml puromycin.
Western blotting and Co-immunoprecipitation (Co-IP)
For Western blotting, cell extracts were prepared in RIPA lysis
buffer (50 mM Tris pH 7.5, 0.1% SDS, 1% Nonidet P40, 0.5%
sodium deoxycholate, 2 mM EDTA, 150 mM NaCl) containing
protease inhibitor cocktail (Roche, Mannheim Germany). Protein
samples were separated on 7.5% reducing SDS gels and
electroblotted onto PVDF membranes. After the transfer, blocking
of unspecific binding sites was achieved by incubation in TBST
(50 mM Tris/HCl, 150 mM NaCl, 0.5% Tween 20, pH 7.2)
containing 5% skimmed milk. For the incubation steps with
primary and HRP-conjugated secondary antibodies, antibody
concentrations were used as recommended by the manufacturer.
Detection was performed with the ECL kit (GE Healthcare,
Munich, Germany) using the FX7 chemoluminescence documen-
tation system (Peqlab, Erlangen, Germany). For Co-IP, U2OS
cells were co-transfected with the expression vectors pOS-9-V5
and pPHD2-His. After 48 h, cells were lysed in NP40 lysis buffer
(1% Nonidet P40, 150 mM NaCl, 2 mM EDTA, 10 mM sodium
phosphate, pH 7.2) and directly subjected to immunoisolation
with a biotinylated antibody against V5-tag for 2 h at 4uC.
Immune complexes were recovered by incubation with streptavi-
din agarose (Invitrogen) for 1 h at 4uC. The beads were washed 3
times with NP40 buffer, resuspended in sample buffer and boiled
for 5 min at 95uC. After removal of the beads by centrifugation,
the supernatant was analyzed by reducing SDS-PAGE and
immunoblotting.
Subcellular fractionation
For isolation of the cytoplasm, the cells were trypsinized and
washed in sucrose buffer (5 mM sucrose, 1 mM Hepes, pH 7.4),
resuspended in sucrose buffer supplemented with 50 mg/mL
digitonin and incubated on ice for 2 min. Following centrifugation
(1 min, 800 g, 4uC), the supernatant was removed and designated
the cytoplasmic fraction. The pellet was washed several times with
digitonin-free sucrose buffer and was used as the organelle fraction
which was solubilized in RIPA buffer. Both fractions were
subjected to SDS-PAGE and immunoblotting. For isolation of
the nuclear fraction, cells were lysed using the NE-PER Nuclear
and Cytoplasmic Extraction Kit (Thermo Scientific, Rockford,
USA). For isolation of the endomembranes, cells were trypsinized,
washed in PBS and resuspended in hypotonic buffer HB (10 mM
Hepes, 10 mM MgCl2, 42 mM KCl, protease inhibitors, pH 7.4)
and incubated on ice for 5 min. Cells were broken with 3–5
passages through a 30KG needle and centrifuged (600 g, 10 min,
4uC) to separate the postnuclear supernatant from the pellet
containing the crude-nuclei-fraction. The postnuclear supernatant
was subjected to an ultracentrifugation step (100000 g, 90 min,
4uC) to separate endomembranes (pellet) from cytosol (superna-
tant). The pellet was washed three times with HB, resuspended in
1 M KCl and incubated for 20 min on ice. The supernatant was
isolated and designated the wash fraction. After extensive washing
in HB, the pellet was resuspended in RIPA buffer. Endomem-
branes, cytosolic fraction and wash fraction were subjected to
SDS-PAGE and immunoblotting.
Fluorescence resonance energy transfer (FRET)
FRET measurements were performed as described previously
[31]. Briefly, HEK293 cells were transfected transiently for 48 h
with the appropriate ECFP- and EYFP-fusion plasmids. The cell
culture dishes were subjected to in vivo imaging on the microscope
stage. An inverted microscope (Axiovert 200 M, Carl Zeiss
Microimaging GmbH, Germany) coupled to a Nipkow Disc
system QLC100 (Visitech International Ltd., UK) was used for
confocal microscopy. Two diode-pumped solid state lasers
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(YFP). The emitted light was detected after passage through the
Nipkow disc unit with a CCD camera (Orca ERG, Hamamatsu,
Japan). To avoid bleaching, a Multispec MicroimagerDualView
beam splitter (Optical Insights, Tucson, AZ) was installed for
simultaneous detection of two emission wavelengths on the CCD
chip. Assuming that the value of non-radiation relaxation
processes during/after FRET is negligible we calculated FRET
efficiency for each pixel in the images by the following formula:
FRETeff~
Fcorr
FcorrzG   IDD
where
Fcorr~IDA{a   IAA{c   IDD ðÞ {d   IDD{b   IAA ðÞ
In this formula, the factor G relates the FRET efficiency to the
acceptor photo bleaching method and therefore renders the
resulting FRET efficiency independent of the underlying imaging
setup as described earlier [32].
I denotes the pixel-by-pixel intensity as captured by the camera.
Indices of I represent excitation source and detection channel,
respectively (IDA=acceptor emission intensity during donor
excitation; IAA=acceptor emission intensity during acceptor
excitation; IDD=donor emission intensity during donor excita-
tion). Factors a–d are bleedthrough and crosstalk calibration
factors. All factors were determined as described by Zal and
Gascoigne [32]. To obtain various acceptor to donor (A/D) ratios,
transfections were conducted with different DNA ratios of
acceptor/donor plasmids (1:1 up to 5:1) to achieve FRET
efficiencies over this range of values. The relationship between
FRET efficiency and A/D ratio was modeled with a simple 1:1
ligand binding model as described before [33,34]. For statistical
analysis of the FRET results the software programs ‘‘ANUFIS’’
(Automated and Uncomplicated FRET Imaging Solution) [35]
and SigmaPlot 2004 (SYSTAT, Chicago, USA) were used. For
interpretation of the FRET measurements, only data from A/D
ratios higher than 1 of the resulting regression functions were
considered, since lower A/D ratios favour the noise level over the
signal and are therefore highly prone to measurement errors.
Furthermore, at high A/D ratios, the probability for donors which
are not paired with acceptors tends towards zero. In such cases
FRET efficiency converges to its theoretical value for a one-
dimensional scenario as characterized by the Fo ¨rster equations.
Results
OS-9 interacts with PHD2 in vitro but not with HIF-1a
Data published previously showed a strong interaction of OS-9
with HIF-1a and PHD-2 and suggested a direct role of OS-9 in
oxygen-dependent degradation of HIF-1a in the cytoplasm [1].
However, subsequent studies performed by several independent
research teams revealed that OS-9 also plays an important part in
the ER degradation pathway of misfolded proteins (ERAD). The
initial focus of this study was to describe the role of OS-9 in the
regulation of O2 homeostasis more precisely. In a first set of
experiments we established OS-9 Western blotting using a
commercial antibody raised against OS-9: Two of the 3 splice
variants described previously [36] were detectable in various
transformed and untransformed cell lines (Fig. 1A). Alternative
splicing was confirmed by RT-PCR. Sequencing of RT-PCR
products from U2OS total RNA identified version 1 which
contains all exons and version 2 which lacks exon 13. Both splice
variants had a half-life of approximately 4 hours (Fig. 1B) and
their expression levels were not influenced by hypoxia or DMOG
(Fig. 1C). Next, we investigated the binding ability of OS-9 to
PHD2 in human cells. After co-transfection of U2OS cells with
expression vectors encoding hexahistidine tagged PHD2 and V5-
tagged OS-9, the cell lysates were incubated with a biotinylated
anti-V5 antibody. Analysis of the immunoprecipitated fraction by
Western blotting indeed revealed protein interaction between
PHD-2 and OS-9 (Fig. 1D, lane 2). Interestingly, we were not able
to detect any endogenous PHD-2 or OS-9 after immunoprecip-
itation when the cells were transfected with a single plasmid
encoding V5-tagged OS-9 or PHD2, respectively (Fig. 1D, lane 3
and 4). To demonstrate protein binding of OS-9 and HIF-1a as
well, we performed another co-immunoprecipitation experiment
using expression vectors for V5-tagged OS-9 and HIF-1a.
However, in our hands no co-immunoprecipitation of HIF-1a
was detectable (data not shown).
Oxygen-dependent regulation of HIF-1a is independent
of OS-9
To examine whether the protein interaction between OS-9 and
PHD2 has relevance for the regulation of HIF-1a in living cells, we
performed gain- and loss-of-function experiments. Initially, we
overexpressed OS-9 transiently in U2OS cells and analyzed the
HIF-1a level under normoxic and hypoxic conditions by
immunoblotting (Fig. 2A). In normoxia, HIF-1a was not
detectable due to complete oxygen-dependent degradation
(Fig. 2A, upper panel). Notably, we were unable to demonstrate
a significant difference in the level of HIF-1a neither when the
oxygen concentration was close to anoxia nor under hypoxia (1%
and 3% O2). A cell type specific effect seemed unlikely since this
experiment showed the same outcome in two other cell lines,
HeLA and Hep3B (Fig. 2A, lower panel). Next, we treated U2OS
cells with tunicamycin and thapsigargin. Both reagents induce
upregulation of ER chaperones by ER stress. We tested the cell
lysates for BiP, OS-9 and HIF-1a expression (Fig. 2B). As
expected, the expression of one of the major ER chaperones, BiP,
was induced under ER stress in normoxia and hypoxia (Fig. 2B,
lanes 1–2, 6–7). Since the level of OS-9 was elevated after ER
stress as well, this indicated a link between OS-9 and the ER.
Remarkably, in hypoxia HIF-1a induction was enhanced in
response to ER stress while the OS-9 levels were elevated as well
(Fig. 2B, lanes 6–8). In addition, we treated the cells under
normoxia with the prolyl hydroxylase inhibitor DMOG to
monitor whether stabilized HIF-1a shows an effect on the
expression level of OS-9 (Fig. 2B, lane 3). However, and in line
with Fig. 1C, this was clearly not the case which implies that OS-9
is not a target gene of HIF-1a. Finally, we tested whether the loss
of function of OS-9 influences cellular HIF-1a protein. To
suppress OS-9 expression, lentiviral particles which induce
production of a small hairpin RNA against OS-9 were used to
infect U2OS cells. The transduced cell line showed a significant
OS-9 knockdown in normoxia and hypoxia when compared to the
control cells (Fig. 2C). In line with the results of the gain-of-
function experiments, inhibition of OS-9 did not have a detectable
influence on HIF-1a expression levels, neither in normoxia nor in
hypoxia with or without ER stress. Noteworthy, under normoxia,
HIF-1a remained undetectable which suggests that degradation by
PHD2 was not impaired in the OS-9 knockdown cell line (Fig. 2C,
lane 1 and 2). Additional experiments were conducted in U2OS
cells with a transient knockdown of OS-9 by transfection of the
cells with specific siRNA. The efficiency of OS-9 knockdown by
siRNA transfection was variable. However, and in line with our
results for the lentivirally mediated OS-9 knockdown, HIF-1a
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(data not shown). The siRNA data also exclude unspecific effects
of the lentiviral infection on the outcome of the experiments.
Discrepant localization of OS-9 and PHD2 in the cell
Although a robust protein interaction between OS-9 and PHD2
was confirmed in our co-IP experiments, OS-9 did not have any
physiological impact on the oxygen-dependent regulation of HIF-
1a in living cells as reported previously. In order to clarify this
apparent discrepancy, we decided to investigate whether both
proteins co-localize under physiological conditions, i.e. when cell
compartments are fully intact. OS-9 shows an N-terminal leader
peptide but lacks a typical C-terminal ER-retention signal (KDEL)
suggesting at least transient localization in the ER, the cell
compartment where glycosylation and folding of most export
proteins take place. Since OS-9, PHD2 and HIF-1a all possess
potential glycosylation sites (Asp-X-Ser/Thr), we tested them for
glycosylation as an index for presence in the ER. Thus, cell lysates
of U2OS cells were incubated with two different endoglycosidases
and subsequently analyzed by Western blot (Fig. 3A). EndoH
cleaves off high mannose carbohydrates which is typical for
glycoproteins of the ER, whereas PNGaseF deglycosylates also
complex oligosaccharides from glycoproteins travelling through
the Golgi. In contrast to PHD2 and HIF-1a, a pronounced
mobility shift identified OS-9 as a glycoprotein when treated with
either endoglycosidase (Fig. 3A, compare lane 1 with lane 2 and 3).
A minor fraction of OS-9 with a lower molecular weight was
visible, indicating a second, unglycosylated form of OS-9 (Fig. 3A,
lane 1). However, this naturally non-glycosylated OS-9 has the
same mobility as the Endo H- or PNGase-cleaved material.
Consequently, it has fully undergone signal peptide cleavage and
translocation into the ER. Hence, OS-9 is presumably a soluble
glycoprotein located in the ER-lumen since sequence analysis did
not predict a membrane anchor. Next, various methods of cell
fractionation were conducted to elucidate the exact cellular
localization of OS-9 and PHD2. First, the nuclear fraction of
HEK293 cells was tested for OS-9 and PHD2 as shown in Fig. 3B.
Under normoxia, endogenous OS-9 and PHD2 were exclusively
detected in the non-nuclear fraction (cytoplasm and organelles) but
not in the nucleus. Of note, when OS-9 was overexpressed, a small
proportion was present in the nuclear fraction (Fig. 3B, lanes 3 and
4). Detection of the ER resident protein BiP, the nuclear protein
lamin A and the cytoplasmic protein GAPDH confirmed integrity
of the cell compartments after fractionation. Subsequently, the
cytoplasm was tested for OS-9 and PHD2. Treatment of the cells
with the mild non-ionic detergent digitonin allows exclusively an
efflux of soluble cytoplasmic proteins through the formation of
pores in the cell membrane. OS-9 was detectable in the organelle
fraction, whereas PHD2 was localized mainly in the cytoplasm
(Fig. 3C). Nevertheless, there was a minor amount of PHD2 found
Figure 1. Initial characterization of the OS-9 protein. (A) OS-9 expression in various human cell lines. Equal protein amounts of total cell lysates
were used for SDS-PAGE and subsequent Western blotting. For each cell line, two independent samples are shown. Endogenous OS-9 was detected
with a polyclonal antibody raised against a peptide corresponding to amino acids 600–667 of isoform 1 of OS-9. (B) Protein stability assay of
endogenous OS-9. U2OS cells were treated with the translational inhibitor cycloheximide (100 mM). At indicated time points, whole cell lysates were
analysed by immunoblotting. (C) Effect of hypoxia on OS-9 expression. For hypoxia, UT-7 cells were exposed to 1% O2 for 24 h prior to Western blot
analysis. To determine any influence of HIF-1a on OS-9 expression under normoxia, cells were incubated with the prolyl hydroxylase inhibitor DMOG
(0.5 mM) for 24 h. (D) Protein interaction between OS-9 and PHD2 in vitro. For co-immunoprecipitation, U2OS cells were transiently co-transfected
with the plasmids pOS-9-V5 and pPHD2-His, lysed in NP40 buffer, and subjected to immunoisolation with anti-V5 antibody recognizing OS-9 by its
V5-tag. OS-9 and its associated proteins were separated by SDS-PAGE and analyzed by Western blot (lane 2). As controls, samples of untransfected
(lane 1) cells or cells transfected with a single plasmid (lanes 3–4) were loaded. Representative Western blots are shown for each subfigure.
doi:10.1371/journal.pone.0019151.g001
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data showing that PHD2 is to some part non-covalently bound to
the peptidyl-prolyl cis/trans isomerase FKBP38, a transmembrane
protein anchored to the cytoplasmic side of the ER membrane
[30]. The control protein GAPDH is typically found in the
cytoplasm (Fig. 3C, lane 2 and 4), but cell stress (here hypoxia) is
known to trigger translocation into the nucleus [37] (Fig. 3C, lanes
3 and 5). However, since we also found PHD2 in the organelle
fraction, we decided to analyze its localization with a different
method in which the organelle fraction is isolated after mechanical
cell disruption and subsequent ultra-centrifugation. As expected,
OS-9 protein was detectable in the organelle fraction, whereas
PHD2 was localized predominantly in the cytoplasm (Fig. 3D). An
additional washing step of the organelle fraction with 1 M KCl did
not reveal OS-9 protein loosely bound to the cytoplasmic side of
the ER membrane as was the case for our cytoplasmic marker
Figure 2. OS-9 shows no effect on regulation of HIF-1a. Total cell lysates were used for SDS-PAGE and subsequent Western blotting. To
generate nearly anoxic conditions, cells were exposed to an oxygen consuming chemical system or to 1% or 3% O2 for 4 h to generate hypoxia. (A)
U2OS, HeLa and Hep3B cells were transiently transfected with the plasmid pOS-9-V5 48 h prior to the experiment. Lamin A and actin were used as
loading controls. (B) U2OS cells were subjected to ER stress by incubation either with tunicamycin (1 mg/ml) or thapsigargin (0.5 mg/ml) for 20 h. To
detect HIF-1a under normoxia, cells were treated with DMOG (1 mM) for 4 h. A sample of DMSO-only treated cells was loaded to exclude unspecific
side effects of the solvent. (C) U2OS cells were transduced with lentiviral construct pLKO.1-shRNA-OS-9 (shOS-9) mediating a stable knockdown of OS-
9 expression. Control cells (c) were transduced with plasmid pLKO.1-puro. Representative Western blots are shown for each subfigure.
doi:10.1371/journal.pone.0019151.g002
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both, the cytoplasmic and the wash fraction which could argue for
a minimal cytosolic fraction of OS-9. However, since the ER
luminal protein BiP displayed a very similar distribution pattern
after cell fractionation, it seemed more likely that these signals
represent inevitable contaminations.
OS-9 and PHD2 do not show protein-protein interaction
in vivo
In addition to our in vitro approach, we performed protein
interaction studies of OS-9 and PHD2 using FRET (fluorescence
resonance energy transfer) analysis. Due to the dependence of
FRET on proximity, it provides an excellent assay for monitoring
the interaction of two proteins in living and intact cells. The
transfer of energy from the donor PHD2-ECFP to the acceptor
OS-9-EYFP fusion protein can only occur when the two molecules
are in close proximity (,10 nm), consistent with being in
molecular contact [38]. Consequently, various ECFP- and
EYFP-fused OS-9, PHD2, GRP94 and FKBP38 proteins were
expressed in U2OS cells and used in different combinations for
FRET measurements (Fig. 4A). Initially, we determined random
FRET as a control which is derived from random collisions
between EYFP and ECFP only (not fused to any other protein).
This curve depicts a maximum FRET efficiency of approximately
10% (Fig. 4B). However, as one of the proteins under scrutiny
presumably localizes to the lumen of the ER we reasoned that
ECFP/EYFP interaction is not a perfect control. Therefore, we
used PHD2/FKBP38 interaction and OS-9/GRP94 interaction as
positive controls. In contrast, PHD2/GRP94 interaction was
regarded as a negative control because GRP94 is well-documented
to be a luminal ER protein while PHD2 is predominantly
cytoplasmic. Only at very low acceptor to donor ratios the signal
Figure 3. Cellular localization of OS-9 and PHD2. (A) A lectin gel-shift assay was conducted to test for glycosylated proteins. Total cell lysates of
U2OS cells were incubated in the presence or absence of the endoglycosidases EndoH and PNGaseF for 6 h at 37uC. Digest products were separated
on a reducing 10% SDS-PAGE gel which contained concanavalin A co-polymerized in the top layer of the separating gel to retard mobility of
glycosylated proteins [56]. Glycosylated OS-9 is indicated as ‘g’, deglycosylated OS-9 as ‘d’. (B) Detection of OS-9 and PHD2 in the nuclear fraction.
HEK293 cells with and without transfection of the plasmid pcDNA3-OS-9 were separated into nuclear fraction (N) and postnuclear supernatant (PS),
the latter containing cytoplasm and organelles. Western blot analysis included BiP, GAPDH and lamin A as typical marker proteins for the ER, the
cytoplasm and the nucleus, respectively. (C) Detection of OS-9 and PHD2 in the cytoplasm. HEK293 cells were co-transfected with pcDNA3-OS-9 and
pPHD2-V5. For hypoxia, cells were exposed to 3% O2 for 4 h. Cells were treated with 50 mg/ml digitonin and centrifuged to obtain a cytoplasmic (C)
and an organelle fraction (O) and subjected to immunoblotting. (D) Isolation of cellular endomembranes. HEK293 cells were lysed mechanically by
several passages through a 30KG needle. The postnuclear supernatant was processed further by ultra-centrifugation to separate the organelles (O)
from the cytosol (C). High salt treatment (1 M KCl) of the organelle fraction produced a wash fraction (W) that contained dissociated peripheral
membrane proteins. For immunoblot analysis of subcellular fractionations, cell aliquots were normalized for cell number prior to loading (B–D).
Representative Western blots are shown for each subfigure.
doi:10.1371/journal.pone.0019151.g003
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(Fig. 4B). These experiments demonstrated that FRET levels did
not exceed background when PHD2 interaction with OS-9 was
tested (,10% maximum FRET efficiency) suggesting no specific
interaction between these two molecules. However, clearly positive
FRET signals were found when OS-9 and GRP94 or when PHD2
and FKBP38 (.20% maximum FRET efficiency) were expressed
(Fig. 4B), confirming interactions of these proteins as published
previously [3,30]. As depicted in Fig. 4C, the images taken from
the CFP- and YFP-emission channels revealed clearly a cytoplas-
mic distribution of PHD2 in contrast to OS-9 and GRP94 which
are both localized in a perinuclear compartment. Collectively,
these data suggest that under physiological conditions, OS-9 and
PHD2 are unable to interact in vivo due to their localization in
different compartments of the cell, OS-9 in the ER lumen and
PHD2 in the cytoplasm.
Discussion
The oxygen sensing prolyl hydroxylases PHD2 and PHD3 play
a central role in the regulation of cell metabolism because they
constantly initiate degradation of HIF-a as long as oxygen is
present. The reduction of enzyme turnover by a lack of oxygen
consequently leads to the activation of HIF which in turn
stimulates transcription of approximately 2% of all active genes
for example in endothelial cells [39]. Importantly, several
situations have been described in which HIF is active despite
normal levels of oxygen. This normoxic activation may be caused
by enhanced transcription of the HIF-1a gene itself [40,41] or by a
defect of HIF-a degradation, e.g. when cells are deficient in
functional pVHL [42] or when elevated levels of TCA cycle
intermediates inhibit the HIF hydroxylases [43]. Remarkably,
previous studies suggested that calcium depletion and ER stress
can also affect hypoxic signaling either via interference with the
regulation of HIF [26–28] or via HIF-independent pathways [44].
The protein OS-9 was reported to be involved in both, the activity
regulation of HIF and ER associated degradation, and thus
promised to be a molecular link between these processes.
The ER represents the site of synthesis for most glycoproteins
destined for secretion or for integration into the plasma membrane
[45]. It also functions as the main Ca
2+ repository of the cell which
is pivotal for nascent proteins to reach their native conformation.
AC a
2+ reduction in this organelle results in impaired protein
folding and ER stress [46]. Non-native substrates are held back in
the ER and finally selected for a process termed ERAD which
leads to retrotranslocation into the cytosol, ubiquitination and
degradation by the 26S proteasome [47]. Recent reports suggest
that mannose trimming of misfolded glycoproteins by ER
mannosidases in conjunction with EDEM1-3 generates an
oligosaccharide form that serves as a degradation signal [48–50].
This promotes interaction with the newly characterized ERAD
component OS-9 which facilitates its targeting to the retro-
translocation channel, although the detailed molecular mechanism
behind this process is still not fully understood [2,3,51].
The initial study which implicated OS-9 in PHD regulation was
based on a yeast two hybrid screen which identified OS-9 as a
protein interacting with HIF. Within this report physical
interaction of over-expressed OS-9 with HIF-1a and PHD2 was
detected in cultured cells by co-immunopreciptitation. Addition-
ally, cell fractionation experiments were performed in a way which
discriminates between nucleus and cytoplasm. In one study
published recently interaction of OS-9 with HIF could not be
confirmed [52] which is in line with our data. Using a new,
commercially available antibody raised against endogenous OS-9
we first demonstrated that OS-9 is expressed in transformed as
well as untransformed cell lines that OS-9 has a protein half-life of
approximately 4 hours and that OS-9 expression is not regulated
by hypoxia. Of note, several components of the HIF system are
hypoxia-inducible such as PHD2 and thus modify activity of the
system in a feedback loop. However, the antibody was not sensitive
enough to be used in immunofluorescence experiments. Although
our experiments also showed binding of OS-9 to PHD2 in vitro we
were unable to demonstrate effects of OS-9 manipulation on HIF
regulation. We over-expressed OS-9 or attempted to reduce OS-9
levels either by transient transfection of short interfering RNA or
short hairpin vectors. Interestingly, transient transfection methods
had no effect or led to a variable reduction of cellular OS-9 levels.
Of note, however, when incubated in hypoxia siRNA transfected
cells did not display a significant correlation between the reduction
of OS-9 levels and the hypoxic induction of HIF. We achieved a
better knockdown of OS-9 when we constructed recombinant
lentiviral particles to deliver short hairpin vectors to cultured cells.
These vectors integrate into the host genome and lead to a stable
reduction of target gene expression. In our hands, the OS-9
knockdown was stable for three weeks at least. Disappointingly,
despite high efficiency of the OS-9 knockdown the cells responded
normally to hypoxia in terms of HIF regulation.
We noted that subcellular localization of OS-9 was discussed
controversially in recent reports. While one group found OS-9
attached to the cytoplasmic side of the ER membrane [25] other
groups reported that OS-9 is a luminal ER protein [53]. Of note,
in one case a leakage of OS-9 out of the ER lumen was
documented, but only when OS-9 was substantially overexpressed
[3]. Cell fractionation experiments cannot provide unequivocal
evidence that all OS-9, endogenous as well as overexpressed,
localizes to the lumen of the ER. On some occasions we detected
OS-9 in the nuclear compartment. This result is, however, not
surprising since the ER is bound tightly to the nuclear envelope
and there may even be some exchange between nuclear and ER
proteins. Clearly, OS-9 best co-localized to BiP which is a marker
for luminal ER proteins. We also performed high salt washes of
endosome preparations to exclude binding of OS-9 to the
cytoplasmic side of the ER. This procedure did not lead to a
release of OS-9 from the endosomes. Because OS-9 does not
possess a transmembrane domain these experiments strongly
argue in favor of an indeed luminal localization.
Nevertheless we intended to analyze in vivo protein interaction
between OS-9 and PHD2 to prove or disprove binding in a
Figure 4. FRET analysis of protein interaction between OS-9 and PHD2. HEK293 cells were transiently co-transfected with the appropriate
ECFP- and EYFP fusion plasmids. After 48 h, live-cell imaging was conducted by confocal microscopy. (A) FRET efficiencies for each ECFP- and EYFP
fusion protein pair were calculated from 25–45 randomly selected cells which displayed various fluorescent acceptor/donor ratios. (B) Scatter plots
were fit to a single-site binding model. FRET efficiency E is defined as the percentage of transferred energy relative to the energy absorbed by the
donor. Additional details are given under ‘Materials and Methods’. For random FRET, cells were co-transfected with plasmids pECFP-N1 and pEYFP-N1
expressing non-fused ECFP and EYFP. (C) Fluorescent images of co-transfected cells were acquired separately through CFP- and YFP-filter channels
using a 406objective. The fluorescence intensity is visualized in false colors on a color bar from low (blue) to high intensity (white). Marked by red
arrows are cellular areas of very low fluorescence intensity in the CFP-filter channel and of high fluorescence intensity in the YFP-filter channel. Each
experiment was performed at least three times, representative data are shown.
doi:10.1371/journal.pone.0019151.g004
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end we used fluorescence resonance energy transfer (FRET) which
we have used previously to analyze binding of HIF-1a to HIF-1b
[54] and to prove interaction of PHD2 with the cis/trans prolyl
isomerase FKBP38 [30]. We fused the PHD2 coding sequence to
ECFP and the OS-9 coding sequence to EYFP. In theory, a
positive FRET signal requires physical contact of the fusion
proteins, because only in this case energy can be transferred from
the donor protein ECFP to the acceptor EYFP. In reality,
however, in addition to random collisions of ECFP and EYFP
which both localize to the same subcellular compartments, there is
a weak but detectable overlap between the emission spectra of
ECFP and EYFP which we tried to correct mathematically. At
very low acceptor to donor ratios an arguable, low level of FRET
signal was detectable in OS-9/PHD2 interaction experiments.
Finally, we used organelle specific FRET between OS-9 and
GRP94 as a positive control. GRP94 is a well-characterized
luminal ER protein and was reported previously to interact with
OS-9 [3]. Interaction experiments of OS-9 with GRP94 gave a
strong FRET signal. As reported previously we also confirmed
PHD2 interaction with FKBP38 as an example of a protein which
robustly interacts with PHD2 in vivo. We then tested PHD2
interaction with GRP94 to define the background level of
fluorescent emissions of the acceptor protein EYFP in our FRET
system. In this experiment, we also measured low level FRET
signals at very low acceptor to donor ratios. Importantly, OS-9/
GRP94 FRET signals exceeded OS-9/PHD2 FRET signals.
Therefore our results demonstrate that OS-9-EYFP interaction
with PHD2-ECFP does not exceed background levels and make
physical interaction of OS-9 with PHD2 in living cells highly
unlikely.
It remains unclear what the molecular link between ER stress
and HIF-dependent signaling is. Indeed we have repeatedly
noticed an augmentation of HIF activation by tunicamycin and
thapsigargin. These substances induce ER stress in different ways:
tunicamycin blocks N-linked glycosylation of nascent proteins
while thapsigargin inhibits the ER Ca
2+ pumps [55]. In our hands
both agents induce BiP and OS-9 which supports recent reports
that demonstrate OS-9 induction by ER stress [53]. Simultaneous
induction of HIF and OS-9, however, strongly argues against
activation of HIF hydroxylases by direct physical interaction with
OS-9. Therefore the molecular link between hypoxic and ER
stress signaling is still elusive.
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